Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hartmann

Showing results (111-120 of 198) with videos related to

Pageof 20
Sort By:
Transplantation Research|February 2, 2013
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipientsHåvard Loftheim, Karsten Midtvedt, Anders Hartmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2016
Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteriaIvar Anders Eide, Thea Anine Strøm Halden, Anders Hartmann, et al.
Clinical Transplantation|February 7, 2020
Endothelial function after pancreas transplantation-A single-center observational studyEspen Nordheim, Dag Olav Dahle, Thea Halden, et al.
Transplantation|September 16, 2014
High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipientsYuliya V Smedbråten, Solbjørg Sagedal, Geir Mjøen, et al.
Transplantation|August 28, 2014
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitusIvar Anders Eide, Thea Anine Strøm Halden, Anders Hartmann, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy studyGudrun E Norby, Erik H Strøm, Karsten Midtvedt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 26, 2018
High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort studyErlend Johannessen Egeland, Anna Varberg Reisaeter, Ida Robertsen, et al.
Antiviral Therapy|August 26, 2009
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovirGuy Boivin, Nathalie Goyette, Halvor Rollag, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantationAnders Åsberg, Karsten Midtvedt, Mike van Guilder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR TrialAnders Åsberg, Atul Humar, Halvor Rollag, et al.
Pageof 20

Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
Transplantation Research|February 2, 2013
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipientsHåvard Loftheim, Karsten Midtvedt, Anders Hartmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2016
Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteriaIvar Anders Eide, Thea Anine Strøm Halden, Anders Hartmann, et al.
Clinical Transplantation|February 7, 2020
Endothelial function after pancreas transplantation-A single-center observational studyEspen Nordheim, Dag Olav Dahle, Thea Halden, et al.
Transplantation|September 16, 2014
High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipientsYuliya V Smedbråten, Solbjørg Sagedal, Geir Mjøen, et al.
Transplantation|August 28, 2014
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitusIvar Anders Eide, Thea Anine Strøm Halden, Anders Hartmann, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy studyGudrun E Norby, Erik H Strøm, Karsten Midtvedt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 26, 2018
High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort studyErlend Johannessen Egeland, Anna Varberg Reisaeter, Ida Robertsen, et al.
Antiviral Therapy|August 26, 2009
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovirGuy Boivin, Nathalie Goyette, Halvor Rollag, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantationAnders Åsberg, Karsten Midtvedt, Mike van Guilder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR TrialAnders Åsberg, Atul Humar, Halvor Rollag, et al.
Pageof 20